These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2199953)

  • 81. [The pharmaco-erection test].
    Fontana D; Rolle L; Del Noce G; Tamagnone A; Rosso C
    Arch Ital Urol Androl; 1994 Sep; 66(4):195-9. PubMed ID: 7951357
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 83. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting: outcomes of 18 consecutive patients.
    Vickers MA; De Nobrega AM; Dluhy RG
    J Urol; 1993 May; 149(5 Pt 2):1258-61. PubMed ID: 8479009
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The diabetes physician and an assessment and treatment programme for male erectile impotence.
    Alexander WD
    Diabet Med; 1990 Jul; 7(6):540-3. PubMed ID: 2142058
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Diagnostic evaluation of erectile dysfunction in the era of oral therapy.
    Sharlip ID
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S12-4. PubMed ID: 11035381
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pathophysiology and diagnosis of male erectile dysfunction.
    Wagner G; Mulhall J
    BJU Int; 2001 Oct; 88 Suppl 3():3-10. PubMed ID: 11578272
    [No Abstract]   [Full Text] [Related]  

  • 88. Cardiovascular reflexes in the neurological evaluation of impotence.
    Nisén HO; Larsen A; Lindström BL; Ruutu ML; Virtanen JM; Alfthan OS
    Br J Urol; 1993 Feb; 71(2):199-203. PubMed ID: 8461955
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Eicosanoids, impotence and pharmacologically induced erection.
    Mikhailidis DP; Jeremy JY; Shoukry K; Virag R
    Prostaglandins Leukot Essent Fatty Acids; 1990 Aug; 40(4):239-42. PubMed ID: 1980365
    [No Abstract]   [Full Text] [Related]  

  • 90. Effect of increased prolactin and psychosocial stress on erectile function.
    Fiala L; Lenz J; Sajdlova R
    Andrologia; 2021 May; 53(4):e14009. PubMed ID: 33595132
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Examination of impotence by recording the physiological reaction to sexual stimulation].
    Kawanishi Y; Imagawa A
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1421-8. PubMed ID: 3807087
    [No Abstract]   [Full Text] [Related]  

  • 92. The investigation of impotence.
    Jeffcoate WJ
    Br J Urol; 1991 Nov; 68(5):449-53. PubMed ID: 1747715
    [No Abstract]   [Full Text] [Related]  

  • 93. Diagnostic and treatment strategies for erectile dysfunction: the 'Process of Care' model. [University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School].
    Padma-Nathan H
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S119-21. PubMed ID: 11035398
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.
    Lea AP; Bryson HM; Balfour JA
    Drugs Aging; 1996 Jan; 8(1):56-74. PubMed ID: 8785470
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intracavernous prostaglandin E1 in erectile dysfunction.
    Linet OI; Neff LL
    Clin Investig; 1994 Jan; 72(2):139-49. PubMed ID: 8186662
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Routine prolactin measurement is not necessary in the initial evaluation of male impotence.
    Akpunonu BE; Mutgi AB; Federman DJ; York J; Woldenberg LS
    J Gen Intern Med; 1994 Jun; 9(6):336-8. PubMed ID: 8077999
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Diagnostic evaluation of impotence.
    Whitehead ED; Klyde BJ; Zussman S; Salkin P
    Postgrad Med; 1990 Aug; 88(2):123-6, 129-36. PubMed ID: 2199953
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Diagnosis and therapy of erectile impotence with special reference to papaverine].
    Schnyder von Wartensee M; Studer UE
    Schweiz Med Wochenschr; 1986 Jul; 116(30):994-9. PubMed ID: 3529377
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Endocrine causes of impotence. Optimistic outlook for restoration of potency.
    Braunstein GD
    Postgrad Med; 1983 Oct; 74(4):207-17. PubMed ID: 6622311
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.